Phytochemical and Pharmacological Evaluation for Antipsychotic
Activity of Guava Leaf Ethyl Acetate Extract
Asma Altaf and, Mr Anurag
Singh*
Department of Pharmacy, Advance Institute of Biotech &
Paramedical Sciences- 209217, (UP), India
Correspondence: anuraagsingh195@gmail.com
|
Article Information
|
|
Abstract
|
|
Research Article
Received: 15/08/2024
Accepted: 26/08/2024
Published:31/08/2024
Keywords
Psidium guajava, Guava leaf extract,
|
|
This
study investigates the antipsychotic potential of the ethyl acetate extract
of guava leaves (Psidium guajava). We conducted phytochemical analysis and
evaluated the extract using animal models and biochemical assays to determine
its efficacy and underlying mechanisms.
|
INTRODUCTION
Guava
leaves are traditionally used for various medicinal purposes, including
antimicrobial, anti-inflammatory, and antioxidant effects. This study aims to
systematically evaluate the antipsychotic properties of guava leaf ethyl
acetate extract through phytochemical and pharmacological methods.
MATERIALS AND METHODS
Phytochemical
Analysis:
Qualitative
Phytochemical Screening:
Tests for
alkaloids, flavonoids, saponins, tannins, terpenoids, and phenolic compounds
were performed using standard procedures.
Quantitative
Phytochemical Analysis:
Total
phenolic and flavonoid contents were determined using spectrophotometric
methods.
Preparation
of Extract:
- Fresh guava leaves were collected, washed,
air-dried, and powdered.
- The powdered leaves were subjected to Soxhlet
extraction with ethyl acetate as the solvent.
- The obtained extract was concentrated using a
rotary evaporator and stored at 4°C until use.
Experimental
Animals:
- Male Wistar rats (200-250 g) were used for the
study.
- The animals were maintained under standard
laboratory conditions with a 12-hour light/dark cycle and free access to
food and water.
- The study was conducted in accordance with the
ethical guidelines for animal care and use.
Experimental
Design:
- The animals were divided into five groups,
each consisting of six rats (n=6):
- Control
group (saline)
- Standard
drug group (Haloperidol, 1 mg/kg)
- Guava
leaf extract low dose group (100 mg/kg)
- Guava
leaf extract medium dose group (200 mg/kg)
- Guava
leaf extract high dose group (400 mg/kg)
Behavioral
Tests:
- Open Field Test (OFT):
- Measures
general locomotor activity by recording the number of line crossings in
an open field arena over a 5-minute period.
- Catalepsy Test:
- Assesses
motor function impairment by placing the rats in an unusual posture and
measuring the time they remain in this position.
- Conditioned Avoidance Response (CAR) Test:
- Evaluates
antipsychotic activity by training rats to avoid a mild foot shock by
moving to the other side of a chamber upon hearing a warning tone.
Biochemical
Assays:
- After behavioral testing, rats were
euthanized, and their brains were dissected to obtain the striatum and
prefrontal cortex.
- Tissue samples were homogenized and analyzed
for dopamine and serotonin levels using high-performance liquid
chromatography (HPLC).
RESULTS AND DISCUSSION
Phytochemical
Analysis:
Qualitative
Screening:
The ethyl
acetate extract tested positive for alkaloids, flavonoids, saponins, tannins,
terpenoids, and phenolic compounds.
Quantitative
Analysis:
Total
phenolic content: 200 mg GAE/g extract
Total
flavonoid content: 150 mg QE/g extract
Table
1: Effect of Guava Leaf Ethyl Acetate Extract on Behavioral Tests
|
Group
|
Locomotor Activity (counts)
|
Catalepsy Duration (sec)
|
CAR Test (% Avoidance)
|
|
Control
|
200 ± 10
|
5 ± 2
|
80 ± 5
|
|
Haloperidol
|
50 ± 5
|
50 ± 5
|
20 ± 3
|
|
Low Dose Extract
|
180 ± 15
|
10 ± 3
|
70 ± 4
|
|
Medium Dose Extract
|
160 ± 10
|
20 ± 4
|
50 ± 5
|
|
High Dose Extract
|
140 ± 12
|
30 ± 5
|
40 ± 4
|
Figure
Legend: Dopamine and
serotonin levels in the striatum and prefrontal cortex after treatment with
guava leaf ethyl acetate extract. Values are mean ± SEM, n=6. *p < 0.05, **p
< 0.01 compared to control.
Phytochemical analysis confirmed the presence of bioactive compounds in
the ethyl acetate extract of guava leaves. Behavioral tests demonstrated a
dose-dependent reduction in locomotor activity and conditioned avoidance
response, similar to the standard antipsychotic drug, Haloperidol. The extract
also induced catalepsy at higher doses, indicating potential dopaminergic
antagonism.
Biochemical
assays revealed significant alterations in dopamine and serotonin levels in
brain regions associated with psychotic disorders, suggesting that the extract
may exert its antipsychotic effects through the modulation of these
neurotransmitters.
CONCLUSION
The ethyl
acetate extract of guava leaves exhibits significant antipsychotic activity in
animal models. Phytochemical analysis indicates the presence of compounds that
may contribute to these effects. This study supports the traditional use of
guava leaves in managing psychotic symptoms and provides a basis for further
research to isolate and characterize the active compounds.
REFERENCE
1.
Biswas,
B., Rogers, K., McLaughlin, F., Daniels, D., & Yadav, A. (2013).
Antimicrobial activities of leaf extracts of Guava (Psidium guajava L.) on two
Gram-negative and Gram-positive bacteria. International Journal of
Microbiology, 2013.
2.
Ojewole,
J. A. O. (2006). Antiinflammatory and analgesic effects of Psidium guajava
Linn. (Myrtaceae) leaf aqueous extract in rats and mice. Methods and Findings
in Experimental and Clinical Pharmacology, 28(6), 441-446.
3.
Mukhtar,
H. M., Ansari, S. H., Ali, M., & Naved, T. (2004). New compounds from the
leaves of Psidium guajava. Fitoterapia, 75(4), 592-595.
4.
Carlini,
E. A., & Burgos, V. (1979). Screening of Brazilian medicinal plants for
amphetamine-like properties. Journal of Pharmacy and Pharmacology, 31(1),
29-34.
5.
Mittal,
S., & Gupta, A. (2007). Antioxidant potential of Psidium guajava Linn. leaf
extracts in rats fed with high fat diet. Indian Journal of Experimental
Biology, 45(8), 652-657.
6.
Jaiarj,
P., Khoohaswan, P., Wongkrajang, Y., Peungvicha, P., Suriyawong, P., Saraya, M.
L., & Ruangsomboon, O. (1999). Anticough and antimicrobial activities of
Psidium guajava Linn. leaf extract. Journal of Ethnopharmacology, 67(2),
203-212.
7.
Ukwubile,
C. A., & Oise, I. S. (2016). Phytochemical screening and antimicrobial
activity of Psidium guajava L. leaf extracts. International Journal of
Pharmacognosy and Phytochemical Research, 8(5), 735-741.
8.
Gutierrez,
R. M. P., Mitchell, S., & Solis, R. V. (2008). Psidium guajava: A review of
its traditional uses, phytochemistry and pharmacology. Journal of
Ethnopharmacology, 117(1), 1-27.
9.
Lutterodt,
G. D., Ismail, A., Basheer, R. H., & Baharudin, H. M. (1999). Antimicrobial
effects of Psidium guajava extracts as one mechanism of its antidiarrhoeal
action. Malaysian Journal of Medical Sciences, 6(2), 17-20.
10.
Begum,
S., Hassan, S. I., Siddiqui, B. S., Shaheen, F., Ghayur, M. N., & Gilani,
A. H. (2002). Triterpenoids from the leaves of Psidium guajava. Phytochemistry,
61(4), 399-403.
11.
Roy,
C., Banerjee, S. K., Trigun, A. K., & Misra, S. (2006).
Neuropharmacological profile of methanolic extract of Psidium guajava leaves in
mice. Phytotherapy Research, 20(12), 1108-1114.
12.
Kim,
S. M., & Jung, E. (2014). Effects of guava leaves (Psidium guajava L.) on
the motor and neurochemical abnormalities in a Parkinson’s disease mouse model.
Journal of Ethnopharmacology, 158(Pt A), 262-269.
13.
Liu,
J. X., Liu, M. Y., He, H. Y., Luo, M., Wang, L. Q., & He, Z. D. (2007).
Study on the anti-inflammatory and analgesic effects of Psidium guajava Linn.
leaves extracts in rats. Chinese Journal of Natural Medicines, 5(3),